Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Documenti analoghi

• Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy
  di: Ben-Shlomo, Anat, et al.
  Pubblicazione: (2009)
• Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response
  di: Ben-Shlomo, Anat, et al.
  Pubblicazione: (2009)
• Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis
  di: Ben-Shlomo, Anat, et al.
  Pubblicazione: (2013)
• Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
  di: Liu, Ning-Ai, et al.
  Pubblicazione: (2011)
• Pituitary Somatostatin Receptor Signaling
  di: Ben-Shlomo, Anat, et al.
  Pubblicazione: (2010)